Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Return on Invested Capital (2016 - 2025)

Amphastar Pharmaceuticals has reported Return on Invested Capital over the past 12 years, most recently at 0.03% for Q4 2025.

  • Quarterly results put Return on Invested Capital at 0.03% for Q4 2025, down 20.0% from a year ago — trailing twelve months through Dec 2025 was 0.03% (down 20.0% YoY), and the annual figure for FY2025 was 0.03%, down 17.0%.
  • Return on Invested Capital for Q4 2025 was 0.03% at Amphastar Pharmaceuticals, down from 0.16% in the prior quarter.
  • Over the last five years, Return on Invested Capital for AMPH hit a ceiling of 1.0% in Q4 2023 and a floor of 1.74% in Q1 2024.
  • Median Return on Invested Capital over the past 5 years was 0.13% (2021), compared with a mean of 0.02%.
  • Biggest five-year swings in Return on Invested Capital: tumbled -271bps in 2024 and later surged 192bps in 2025.
  • Amphastar Pharmaceuticals' Return on Invested Capital stood at 0.13% in 2021, then surged by 380bps to 0.61% in 2022, then soared by 65bps to 1.0% in 2023, then tumbled by -76bps to 0.24% in 2024, then plummeted by -86bps to 0.03% in 2025.
  • The last three reported values for Return on Invested Capital were 0.03% (Q4 2025), 0.16% (Q3 2025), and 0.17% (Q2 2025) per Business Quant data.